Literature DB >> 33569059

Advances in Hypofractionated Irradiation-Induced Immunosuppression of Tumor Microenvironment.

Yuxia Wang1.   

Abstract

Hypofractionated radiotherapy is external beam irradiation delivered at higher doses in fewer fractions than conventional standard radiotherapy, which can stimulate innate and adaptive immunity to enhance the body's immune response against cancer. The enhancement effect of hypofractionated irradiation to immune response has been widely investigated, which is considered an approach to expand the benefit of immunotherapy. Meanwhile, increasing evidence suggests that hypofractionated irradiation may induce or enhance the suppression of immune microenvironments. However, the suppressive effects of hypofractionated irradiation on immunomicroenvironment and the molecular mechanisms involved in these conditions are largely unknown. In this context, we summarized the immune mechanisms associated with hypofractionated irradiation, highlighted the advances in its immunosuppressive effect, and further discussed the potential mechanism behind this effect. In our opinion, besides its immunogenic activity, hypofractionated irradiation also triggers homeostatic immunosuppressive mechanisms that may counterbalance antitumor effects. And this may suggest that a combination with immunotherapy could possibly improve the curative potential of hypofractionated radiotherapy.
Copyright © 2021 Wang.

Entities:  

Keywords:  hypofractionated irradiation; immune microenvironment; immunosuppression; radiotherapy; tumor

Year:  2021        PMID: 33569059      PMCID: PMC7868375          DOI: 10.3389/fimmu.2020.612072

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  110 in total

Review 1.  Immune modulation by hypofractionated stereotactic radiation therapy: Therapeutic implications.

Authors:  Ilinca Popp; Anca Ligia Grosu; Gabriele Niedermann; Dan G Duda
Journal:  Radiother Oncol       Date:  2016-08-02       Impact factor: 6.280

Review 2.  The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?

Authors:  J Martin Brown; David J Carlson; David J Brenner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

3.  In Vivo Imaging Reveals Significant Tumor Vascular Dysfunction and Increased Tumor Hypoxia-Inducible Factor-1α Expression Induced by High Single-Dose Irradiation in a Pancreatic Tumor Model.

Authors:  Azusa Maeda; Yonghong Chen; Jiachuan Bu; Hilda Mujcic; Bradly G Wouters; Ralph S DaCosta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-14       Impact factor: 7.038

Review 4.  The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership.

Authors:  Enrique Chajon; Joël Castelli; Hugo Marsiglia; Renaud De Crevoisier
Journal:  Crit Rev Oncol Hematol       Date:  2017-02-04       Impact factor: 6.312

Review 5.  Radiation-induced cell death mechanisms.

Authors:  David Eriksson; Torgny Stigbrand
Journal:  Tumour Biol       Date:  2010-05-20

6.  STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.

Authors:  Ayman J Oweida; Laurel Darragh; Andy Phan; David Binder; Shilpa Bhatia; Adam Mueller; Benjamin Van Court; Dallin Milner; David Raben; Richard Woessner; Lynn Heasley; Raphael Nemenoff; Eric Clambey; Sana D Karam
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

Review 7.  The Abscopal Effect of Stereotactic Radiotherapy and Immunotherapy: Fool's Gold or El Dorado?

Authors:  D Xing; S Siva; G G Hanna
Journal:  Clin Oncol (R Coll Radiol)       Date:  2019-04-17       Impact factor: 4.126

8.  Challenges and opportunities of using stereotactic body radiotherapy with anti-angiogenesis agents in tumor therapy.

Authors:  Xiaowen Sun; Lei Deng; You Lu
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

9.  Radiotherapy in combination with vascular-targeted therapies.

Authors:  Eva Ciric; Gregor Sersa
Journal:  Radiol Oncol       Date:  2010-05-24       Impact factor: 2.991

10.  Time-synchronized immune-guided SBRT partial bulky tumor irradiation targeting hypoxic segment while sparing the peritumoral immune microenvironment.

Authors:  Slavisa Tubin; Martin Ashdown; Branislav Jeremic
Journal:  Radiat Oncol       Date:  2019-12-04       Impact factor: 3.481

View more
  3 in total

Review 1.  A Review of the Effects of Cervical Cancer Standard Treatment on Immune Parameters in Peripheral Blood, Tumor Draining Lymph Nodes, and Local Tumor Microenvironment.

Authors:  Iske F van Luijk; Sharissa M Smith; Maria C Marte Ojeda; Arlene L Oei; Gemma G Kenter; Ekaterina S Jordanova
Journal:  J Clin Med       Date:  2022-04-19       Impact factor: 4.964

Review 2.  Narrative Review of Synergistics Effects of Combining Immunotherapy and Stereotactic Radiation Therapy.

Authors:  François Lucia; Margaux Geier; Ulrike Schick; Vincent Bourbonne
Journal:  Biomedicines       Date:  2022-06-15

Review 3.  Exploiting Radiation Therapy to Restore Immune Reactivity of Glioblastoma.

Authors:  Mara De Martino; Oscar Padilla; Camille Daviaud; Cheng-Chia Wu; Robyn D Gartrell; Claire Vanpouille-Box
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.